Atsak P, Hauer D, Campolongo P, Schelling G, McGaugh JL, Roozendaal B (2012) Glucocorticoids interact with the hippocampal endocannabinoid system in impairing retrieval of contextual fear memory. Proc Natl Acad Sci U S A 109:3504–3509. https://doi.org/10.1073/pnas.1200742109

Article  PubMed  PubMed Central  Google Scholar 

Baas JMP, Grillon C, Böcker KB, Brack AA, Morgan CA 3rd, Kenemans JL, Verbaten MN (2002) Benzodiazepines have no effect on fear-potentiated startle in humans. Psychopharmacology 161:233–247. https://doi.org/10.1007/s00213-002-1011-8

Article  PubMed  CAS  Google Scholar 

Baldwin DS, Anderson IM, Nutt DJ, Allgulander C, Bandelow B, den Boer JA, Christmas DM, Davies S, Fineberg N, Lidbetter N, Malizia A, McCrone P, Nabarro D, O’Neill C, Scott J, van der Wee N, Wittchen HU (2014) Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology. J Psychopharmacol 28:403–439. https://doi.org/10.1177/0269881114525674

Article  PubMed  CAS  Google Scholar 

Bates D, Kliegl R, Vasishth S, Baayen, H (2018) Parsimonious mixed models. Preprint at https://arxiv.org/abs/1506.04967.

Bergamaschi MM, Queiroz RHC, Crippa JAS, Zuardi AW (2011) Safety and side effects of cannabidiol, a Cannabis sativa constituent. Curr Drug Saf 6:237–249. https://doi.org/10.2174/157488611798280924

Article  PubMed  CAS  Google Scholar 

Black N, Stockings E, Campbell G, Tran LT, Zagic D, Hall WD, Farrell M, Degenhardt L (2019) Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis. Lancet Psychiatry 6:995–1010. https://doi.org/10.1016/S2215-0366(19)30401-8

Article  PubMed  PubMed Central  Google Scholar 

Blumenthal TD, Cuthbert BN, Filion DL, Hackley S, Lipp OV, van Boxtel A (2005) Committee report: guidelines for human startle eyeblink electromyographic studies. Psychophysiology 42:1–15. https://doi.org/10.1111/j.1469-8986.2005.00271.x

Article  PubMed  Google Scholar 

Boddez Y, Baeyens F, Luyten L, Vansteenwegen D, Hermans D, Beckers T (2013) Rating data are underrated: validity of US expectancy in human fear conditioning. J Behav Ther Exp Psychiatry 44:201–206. https://doi.org/10.1016/j.jbtep.2012.08.003

Article  PubMed  Google Scholar 

Bolsoni LM, Crippa JAS, Hallak JEC, Guimarães FS, Zuardi AW (2022) Effects of cannabidiol on symptoms induced by the recall of traumatic events in patients with posttraumatic stress disorder. Psychopharmacology 239:1499–1507. https://doi.org/10.1007/s00213-021-06043-y

Article  PubMed  CAS  Google Scholar 

Bradford DE, Starr MJ, Shackman AJ, Curtin JJ (2015) Empirically based comparisons of the reliability and validity of common quantification approaches for eyeblink startle potentiation in humans. Psychophysiology 52:1669–1681. https://doi.org/10.1111/psyp.12545

Article  PubMed  PubMed Central  Google Scholar 

Bryk AS, Raudenbush SW (1992) Hierarchical linear models. Sage, Newbury Park, CA

Google Scholar 

Campolongo P, Morena M, Scaccianoce S, Trezza V, Chiarotti F, Schelling G, Cuomo V, Roozendaal B (2013) Novelty-induced emotional arousal modulates cannabinoid effects on recognition memory and adrenocortical activity. Neuropsychopharmacology 38:1276–1286. https://doi.org/10.1038/npp.2013.26

Article  PubMed  PubMed Central  CAS  Google Scholar 

Chan CK, Lovibond PF (1996) Expectancy bias in trait anxiety. J Abnorm Psychol 105:637–647. https://doi.org/10.1037/0021-843X.105.4.637

Article  PubMed  CAS  Google Scholar 

Chesney E, Oliver D, Green A, Sovi S, Wilson J, Englund A, Freeman TP, McGuire P (2020) Adverse effects of cannabidiol: a systematic review and meta-analysis of randomized clinical trials. Neuropsychopharmacology 45:1799–1806. https://doi.org/10.1038/s41386-020-0667-2

Article  PubMed  PubMed Central  CAS  Google Scholar 

Cornwell BR, Johnson L, Berardi L, Grillon C (2006) Anticipation of public speaking in virtual reality reveals a relationship between trait social anxiety and startle reactivity. Biol Psychiatry 59:664–666. https://doi.org/10.1016/j.biopsych.2005.09.015

Article  PubMed  Google Scholar 

Craske MG, Hermans D, Vervliet B (2018) State-of-the-art and future directions for extinction as a translational model for fear and anxiety. Philos Trans R Soc Lond Ser B Biol Sci 373:1742. https://doi.org/10.1098/rstb.2017.0025

Article  Google Scholar 

Craske MG, Liao B, Brown L, Vervliet B (2012) Role of inhibition in exposure therapy. J Exp Psychopathol 3:322–345. https://doi.org/10.5127/jep.0265

Article  Google Scholar 

Cuijpers P, Cristea IA, Karyotaki E, Reijnders M, Huibers MJH (2016) How effective are cognitive behavior therapies for major depression and anxiety disorders? A meta-analytic update of the evidence. World Psychiatry 15:245–258. https://doi.org/10.1002/wps.20346

Article  PubMed  PubMed Central  Google Scholar 

Das RK, Kamboj SK, Ramadas M, Yogan K, Gupta V, Redman E, Curran HV, Morgan CJ (2013) Cannabidiol enhances consolidation of explicit fear extinction in humans. Psychopharmacology 226:781–792. https://doi.org/10.1007/s00213-012-2955-y

Article  PubMed  CAS  Google Scholar 

de Oliveira AL, Engelke DS, Diehl F, Scheffer-Teixeira R, Haubrich J, de Freitas CL, Molina VA, Quillfeldt JA (2010) Stress response recruits the hippocampal endocannabinoid system for the modulation of fear memory. Learn Mem 17:202–209. https://doi.org/10.1101/lm.1721010

Article  CAS  Google Scholar 

De Quervain D, Schwabe L, Roozendaal B (2017) Stress, glucocorticoids and memory: implications for treating fear-related disorders. Nat Rev Neurosci 18:7–19. https://doi.org/10.1038/nrn.2016.155

Article  PubMed  CAS  Google Scholar 

Dincheva I, Drysdale AT, Hartley CA, Johnson DC, Jing D, King EC, Ra S, Gray JM, Yang R, DeGruccio AM, Huang C, Cravatt BF, Glatt CE, Hill MN, Casey BJ, Lee FS (2015) FAAH genetic variation enhances fronto-amygdala function in mouse and human. Nat Commun 6:6395. https://doi.org/10.1038/ncomms7395

Article  PubMed  CAS  Google Scholar 

Duits P, Baas JMP, Engelhard IM, Richter J, Huisman-van Dijk HM, Limberg Thiesen A, Heitland I, Hamm AO, Cath DC (2021) Latent class growth analyses reveal overrepresentation of dysfunctional fear conditioning trajectories in patients with anxiety-related disorders compared to controls. J Anxiety Disord 78:102361

Article  PubMed  Google Scholar 

Duits P, Cath DC, Lissek S, Hox JJ, Hamm AO, Engelhard IM, van den Hout MA, Baas JM (2015) Updated meta-analysis of classical fear conditioning in the anxiety disorders. Depress Anxiety 32:239–253. https://doi.org/10.1002/da.22353

Article  PubMed  Google Scholar 

Duits P, Richter J, Baas JMP, Engelhard IM, Limberg-Thiesen A, Heitland I, Hamm AO, Cath DC (2017) Enhancing effects of contingency instructions on fear acquisition and extinction in anxiety disorders. J Abnorm Psychol 126:378–391. https://doi.org/10.1037/abn0000266

Article  PubMed  Google Scholar 

Englund A, Morrison PD, Nottage J, Hague D, Kane F, Bonaccorso S, Stone JM, Reichenberg A, Brenneisen R, Holt D, Feilding A, Walker L, Murray RM, Kapur S (2013) Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment. J Psychopharmacol 27:19–27. https://doi.org/10.1177/0269881112460109

Article  PubMed  CAS  Google Scholar 

Franzen JM, Werle I, Vanz F, de Oliveira BB, Martins Nascimento LM, Guimarães FS, Bertoglio LJ (2023) Cannabidiol attenuates fear memory expression in female rats via hippocampal 5-HT1A but not CB1 or CB2 receptors. Neuropharmacology 223:109316. https://doi.org/10.1016/j.neuropharm.2022.109316

Article  PubMed  CAS  Google Scholar 

Gandhi M, Aweeka F, Greenblatt RM, Blaschke TF (2004) Sex differences in pharmacokinetics and pharmacodynamics. Annu Rev Pharmacol Toxicol 44:499–523. https://doi.org/10.2165/00003088-200948030-00001

Article  PubMed  CAS  Google Scholar 

Glass M, Faull RLM, Dragunow M (1997) Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience 77:299–318. https://doi.org/10.1016/S03064522(96)00428-9

Article  PubMed  CAS  Google Scholar 

Gloster AT, Hauke C, Höfler M, Einsle F, Fydrich T, Hamm A, Sthröhle A, Wittchen HU (2013) Long-term stability of cognitive-behavioral therapy effects for panic disorder with agoraphobia: a two-year follow-up study. Behav Res Ther 51:830–839. https://doi.org/10.1016/j.brat.2013.09.009

Article  PubMed  Google Scholar 

Grillon C, Morgan CA, Davis M (1998) Effects of experimental context and explicit threat cues on acoustic startle in Vietnam veterans with posttraumatic stress disorder. Biol Psychiatry 44:1027–1036. https://doi.org/10.1016/S0006-3223(98)00034-1

Article  PubMed  CAS  Google Scholar 

Guastella AJ, Lovibond PF, Dadds MR, Mitchell P, Richardson R (2007) A randomized controlled trial of the effect of D-cycloserine on extinction and fear conditioning in humans. Behav Res Ther 45:663–672. https://doi.org/10.1016/j.brat.2006.07.005

Article  PubMed  Google Scholar 

Gunduz-Cinar O, Flynn S, Brockway E, Kaugars K, Baldi R, Ramikie TS, Cinar R, Kunos G, Patel S, Holmes A (2016) Fluoxetine facilitates fear extinction through amygdala endocannabinoids. Neuropsychopharmacology 41:1598–1609. https://doi.org/10.1038/npp.2015.318

Article  PubMed  CAS  Google Scholar 

Gunduz-Cinar O, MacPherson KP, Cinar R, Gamble-George J, Sugden K, Williams B, Godlewski G, Ramikie TS, Gorka AX, Alapafuja SO, Nikas SP, Makriyannis A, Poulton R, Patel S, Hariri AR, Caspi A, Moffitt TE, Kunos G, Holmes A (2013) Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress reactivity. Mol Psychiatry 18:813–823. https://doi.org/10.1038/mp.2012.72

Article  PubMed  CAS